JonesTrading analyst Sean Kim downgrades Concert Pharma (NASDAQ:CNCE) from Buy to Hold.
JonesTrading Downgrades Concert Pharma to Hold
JonesTrading analyst Sean Kim downgrades Concert Pharma (NASDAQ:CNCE) from Buy to Hold.
Related Posts
Blink Charging Collaborates With CityBest To Deploy EV Chargers In Mexico, Chile
70 EV chargers initially scheduled for installation through this alliance to help meet driver demands as LatAm forecasts more than 1 million electric vehicles sold by 2030
Evaluating TPG RE Finance Trust: Insights From 5 Financial Analysts
Ratings for TPG RE Finance Trust (NYSE:TRTX) were provided by 5 analysts in the past three months, showcasing…
Black Knight Q2 EPS $0.65 Beats $0.64 Estimate, Sales $394.50M Beat $393.38M Estimate
Black Knight (NYSE:BKI) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.64 by 1.56 percent. This is a 14.04 percent increase over earnings of $0.57 per share from the same